Gorlin Syndrome in Medulloblastoma Patients
Author Information
Author(s): D.G.R. Evans, P.A. Farndon, L.D. Burnell, H. Rao Gattamaneni, J.M. Birch
Primary Institution: Paterson Institute for Cancer Research; Christie Hospital; Birmingham Maternity Hospital
Hypothesis
What is the incidence of Gorlin syndrome in patients with medulloblastoma?
Conclusion
The incidence of Gorlin syndrome in medulloblastoma patients is likely between 1-2%.
Supporting Evidence
- Only 2 out of 173 cases had evidence of Gorlin syndrome.
- The study found a lower incidence of Gorlin syndrome in medulloblastoma than previously estimated.
- Children under 5 years with medulloblastoma should be examined for signs of Gorlin syndrome.
Takeaway
This study looked at kids with a brain tumor called medulloblastoma to see how many also had Gorlin syndrome, a condition that can cause skin problems. They found that only a few had both conditions.
Methodology
The study reviewed case notes, X-rays, and health surveys of 173 medulloblastoma patients from 1954 to 1989.
Limitations
The study may not have captured all cases of Gorlin syndrome due to the age of onset and the nature of the disease.
Participant Demographics
The study focused on children diagnosed with medulloblastoma between 1954 and 1989.
Want to read the original?
Access the complete publication on the publisher's website